Novavax, Inc. (NVAX)
8.525
-0.24
(-2.68%)
USD |
NASDAQ |
Nov 13, 16:00
8.52
0.00 (0.00%)
After-Hours: 19:59
Novavax Price : 8.525 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 8.77 | 8.785 | 8.35 | 8.525 | 4.643M |
| Nov 12, 2026 | 9.70 | 9.74 | 8.75 | 8.76 | 7.014M |
| Nov 11, 2026 | 10.28 | 10.36 | 9.895 | 9.98 | 5.896M |
| Nov 10, 2026 | 10.60 | 10.71 | 10.06 | 10.20 | 12.27M |
| Nov 09, 2026 | 10.83 | 11.20 | 10.42 | 10.89 | 8.496M |
| Nov 06, 2026 | 10.06 | 10.93 | 9.995 | 10.78 | 6.293M |
| Nov 05, 2026 | 10.34 | 10.68 | 9.39 | 9.78 | 8.216M |
| Nov 04, 2026 | 10.01 | 10.67 | 9.84 | 10.65 | 6.032M |
| Nov 03, 2026 | 9.555 | 9.950 | 9.45 | 9.68 | 3.465M |
| Nov 02, 2026 | 10.10 | 10.38 | 9.485 | 9.53 | 4.088M |
| Oct 30, 2026 | 10.27 | 10.65 | 9.915 | 10.08 | 4.062M |
| Oct 29, 2026 | 10.19 | 10.62 | 10.18 | 10.47 | 2.800M |
| Oct 28, 2026 | 9.79 | 10.34 | 9.74 | 10.32 | 4.748M |
| Oct 27, 2026 | 9.37 | 10.10 | 8.950 | 10.02 | 6.775M |
| Oct 26, 2026 | 9.56 | 9.88 | 9.26 | 9.40 | 4.941M |
| Oct 23, 2026 | 9.84 | 9.93 | 9.615 | 9.70 | 4.419M |
| Oct 22, 2026 | 10.79 | 10.86 | 9.555 | 9.99 | 12.25M |
| Oct 21, 2026 | 11.39 | 11.46 | 10.98 | 11.01 | 5.441M |
| Oct 20, 2026 | 10.75 | 11.57 | 10.55 | 11.43 | 6.526M |
| Oct 19, 2026 | 11.20 | 11.99 | 10.76 | 10.82 | 6.206M |
| Oct 16, 2026 | 12.71 | 12.84 | 11.11 | 11.26 | 9.892M |
| Oct 15, 2026 | 12.50 | 13.25 | 12.18 | 12.82 | 7.367M |
| Oct 14, 2026 | 12.69 | 13.34 | 12.57 | 12.64 | 8.546M |
| Oct 13, 2026 | 12.44 | 13.12 | 12.21 | 12.82 | 8.400M |
| Oct 12, 2026 | 12.61 | 12.96 | 12.19 | 12.66 | 8.505M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 223.37 |
| Merck & Co., Inc. | 147.76 |
| Pfizer Inc. | 28.89 |
| Amgen, Inc. | 465.67 |
| Editas Medicine, Inc. | 2.17 |
Price Related Metrics
| PS Ratio | 3.406 |
| Earnings Yield | -5.47% |
| Market Cap | 1.407B |